Research Library

Peptide Dosage Protocols: Why We Explain Research, Not Prescribe
Research Standards Compliance Compound Research Last Updated: May 2026 If you searched "peptide dosage protocol," you want specific guidance — and Pure Grade Labs is going to give you something more useful: the scientific and legal reasons why authoritative dosing data belongs in peer-reviewed journals and clinical trial registries, not on supplier websites, and exactly where to find it. This article covers the published research parameters for compounds including GHRP-2, BPC-157, and CJC-1295+DAC — what clinical trials actually studied, how researchers read dose-response data from the primary literature, and why... Read more...
Mounjaro Research: How Dual GIP/GLP-1 Agonism Works
GLP-1 Research Metabolic Research Clinical Evidence Last Updated: May 2026 Mounjaro research centres on one molecule: tirzepatide — a 39-amino acid synthetic peptide engineered to simultaneously activate both the GIP (glucose-dependent insulinotropic polypeptide) receptor and the GLP-1 (glucagon-like peptide-1) receptor with balanced affinity, creating a dual incretin signalling profile that no single-receptor agonist can replicate. Across the SURPASS and SURMOUNT clinical trial programmes, tirzepatide produced metabolic effect sizes that substantially exceeded those of GLP-1 mono-agonists such as semaglutide — a finding that has fundamentally reshaped the research landscape for incretin-based... Read more...
Ozempic Research: GLP-1 Signalling & Metabolic Effects Explained
GLP-1 Research Metabolic Research Clinical Evidence Last Updated: May 2026 The reason semaglutide (Ozempic) became the most consequential metabolic research compound of the past decade is not its clinical name recognition — it is the depth of the mechanistic story behind it: a precisely engineered analogue of a short-lived endogenous hormone, redesigned at the molecular level to activate the same receptor for seven days instead of two minutes. Understanding how semaglutide works at the receptor level, how the SUSTAIN trial programme characterised its metabolic profile, and how it sits within... Read more...
Buy Peptides Online: Pure Grade Research-Grade Standards
Research Standards Quality Assurance Compound Research Last Updated: May 2026 The peptide research supply market is saturated — and the quality gap between legitimate research-grade suppliers and grey-market sources is not a minor variation in purity percentage, it is the difference between scientifically reproducible data and meaningless noise. When researchers source compounds like BPC-157, TB-500, and GHRP-2 from unverified sources, they are frequently working with underdosed, degraded, or adulterated material — and their experimental results reflect that. This article defines what research-grade peptide supply actually means in practice: how purity... Read more...
Ozempic vs Mounjaro: GLP-1 vs Dual Agonist Comparison
GLP-1 Research Metabolic Research Comparison Study Last Updated: May 2026 The debate between semaglutide (Ozempic) and tirzepatide (Mounjaro) has become one of the most consequential comparisons in metabolic research — representing two fundamentally different pharmacological strategies for engaging the incretin hormone system. Where semaglutide operates as a selective GLP-1 receptor agonist, tirzepatide simultaneously activates both the GIP and GLP-1 receptors — a dual mechanism that clinical trial data suggests produces differentiated metabolic signalling profiles across glycaemic, cardiovascular, and body composition endpoints. This article examines both compounds through the lens of... Read more...
Mounjaro (Tirzepatide) Research: GIP/GLP-1 Mechanism
Mounjaro (Tirzepatide) Research: GIP/GLP-1 Mechanism | Pure Grade Labs GIP/GLP-1 Research Metabolic Research Dual Agonist Prescription-Only Medicine Last Updated: May 2026 Mounjaro (Tirzepatide) Research: Dual GIP/GLP-1 Mechanism Guide ⚠ Prescription-only medication in many jurisdictions. For research purposes only. Not for human consumption. Mounjaro (tirzepatide) is a dual GIP/GLP-1 receptor agonist that represents a mechanistically distinct class from any prior incretin-based compound — and the distinction matters significantly for researchers investigating the GIP receptor pathway. Where semaglutide (Ozempic, Wegovy) acts exclusively on the GLP-1 receptor, tirzepatide co-activates both the glucose-dependent insulinotropic... Read more...
Ozempic (Semaglutide) Research: GLP-1 Mechanism Guide
GLP-1 Research Metabolic Research Clinical Evidence Last Updated: May 2026 Important Notice Prescription-only medication in many jurisdictions. For research purposes only. Not for human consumption. Ozempic (semaglutide) is a long-acting GLP-1 receptor agonist that has generated more published clinical research data than almost any other metabolic compound of the past two decades — making it one of the most relevant reference molecules for researchers investigating incretin biology, hypothalamic satiety signalling, and GLP-1 receptor pharmacology. This article examines the full GLP-1 receptor mechanism from a research chemistry perspective: how semaglutide engages... Read more...
Peptide Research 101: How Peptides Work at Cellular Level
Research Guide Mechanism of Action Cellular Biology Last Updated: May 2026 Peptide Research 101: How These Compounds Work at Cellular Level Peptide research sits at the intersection of biochemistry, molecular pharmacology, and translational medicine — and understanding the cellular mechanisms behind these compounds is the foundation every serious researcher needs before interpreting the published literature. Whether you are beginning to review data on tissue repair peptides like BPC-157, exploring the GH-axis secretagogue literature around GHRP-2, or simply building your foundational knowledge of peptide science, this guide covers everything from basic... Read more...
Best Peptides for Recovery Research: BPC-157 & TB-500
  Recovery Research   Tissue Repair   Clinical Evidence   Last Updated: May 2026 Best Peptides for Recovery Research: BPC-157, TB-500 & Synergy When researchers ask which peptides appear most frequently in published tissue repair and recovery research, two compounds dominate the literature: BPC-157 and TB-500. With over a hundred published studies between them — spanning tendon repair, skeletal muscle regeneration, angiogenesis, and cardiac tissue models — these two pentadecapeptides represent the most rigorously characterised compounds in the recovery peptide research space. This article reviews the mechanistic and citation evidence... Read more...
BPC-157 & BPC 157: Muscle Protein Synthesis Research Data
Muscle Research Mechanism of Action Clinical Evidence Last Updated: May 2026 BPC-157 is a synthetic pentadecapeptide that has appeared in over 100 published research papers, with a significant portion of the preclinical literature examining its effects on tissue repair, angiogenesis, and muscle protein synthesis pathways. This article reviews what the published data actually shows about BPC 157 and its relationship to muscle protein synthesis in preclinical models — covering the proposed mechanisms, the specific rodent model findings, how BPC157 compares to structurally distinct peptides such as TB-500, and the published... Read more...
Where to Buy BPC Peptide: Research-Grade Supply UK
Research Supply UK Peptides BPC-157 Last Updated: May 2026 When researchers source BPC peptide for tissue and repair studies, the single biggest variable affecting the validity of their data is compound purity — and most of the market fails on this point before the experiment even begins. BPC-157 10mg is one of the most widely studied peptides in the current research literature, with a sequence of 15 amino acids and a published profile spanning tendon repair, gastrointestinal tissue, and neurological models. But the compound's research utility depends entirely on starting... Read more...
BPC vs TB500: Recovery Peptide Research Comparison
BPC vs TB500: Recovery Peptide Research Comparison | Pure Grade Labs Recovery Research Research Comparison Tissue Repair Last Updated: May 2026 BPC vs TB500: Recovery Peptide Research Comparison & Synergy BPC-157 and TB-500 are two of the most extensively studied tissue repair peptides in preclinical research, each operating through distinct molecular mechanisms — yet sharing overlapping applications in musculoskeletal, vascular, and inflammatory models. When researchers compare BPC-157 vs TB-500, they are evaluating two fundamentally different classes of compound. BPC-157 (also written as BPC157) is a synthetic pentadecapeptide derived from a... Read more...
Peptide Research 101: How Peptides Work at Cellular Level
Research Guide Mechanism of Action Cellular Biology Last Updated: May 2026 Peptide Research 101: How These Compounds Work at Cellular Level Peptide research sits at the intersection of biochemistry, molecular pharmacology, and translational medicine — and understanding the cellular mechanisms behind these compounds is the foundation every serious researcher needs before interpreting the published literature. Whether you are beginning to review data on tissue repair peptides like BPC-157, exploring the GH-axis secretagogue literature around GHRP-2, or simply building your foundational knowledge of peptide science, this guide covers everything from basic... Read more...
Mounjaro (Tirzepatide) Research: GIP/GLP-1 Mechanism
Mounjaro (Tirzepatide) Research: GIP/GLP-1 Mechanism | Pure Grade Labs GIP/GLP-1 Research Metabolic Research Dual Agonist Prescription-Only Medicine Last Updated: May 2026 Mounjaro (Tirzepatide) Research: Dual GIP/GLP-1 Mechanism Guide ⚠ Prescription-only medication in many jurisdictions. For research purposes only. Not for human consumption. Mounjaro (tirzepatide) is a dual GIP/GLP-1 receptor agonist that represents a mechanistically distinct class from any prior incretin-based compound — and the distinction matters significantly for researchers investigating the GIP receptor pathway. Where semaglutide (Ozempic, Wegovy) acts exclusively on the GLP-1 receptor, tirzepatide co-activates both the glucose-dependent insulinotropic... Read more...
Ozempic (Semaglutide) Research: GLP-1 Mechanism Guide
GLP-1 Research Metabolic Research Clinical Evidence Last Updated: May 2026 Important Notice Prescription-only medication in many jurisdictions. For research purposes only. Not for human consumption. Ozempic (semaglutide) is a long-acting GLP-1 receptor agonist that has generated more published clinical research data than almost any other metabolic compound of the past two decades — making it one of the most relevant reference molecules for researchers investigating incretin biology, hypothalamic satiety signalling, and GLP-1 receptor pharmacology. This article examines the full GLP-1 receptor mechanism from a research chemistry perspective: how semaglutide engages... Read more...
Best Peptides for Recovery Research: BPC-157 & TB-500
Recovery Research Tissue Repair Clinical Evidence Last Updated: May 2026 Best Peptides for Recovery Research: BPC-157, TB-500 & Synergy When researchers ask which peptides appear most frequently in published tissue repair and recovery research, two compounds dominate the literature: BPC-157 and TB-500. With over a hundred published studies between them — spanning tendon repair, skeletal muscle regeneration, angiogenesis, and cardiac tissue models — these two pentadecapeptides represent the most rigorously characterised compounds in the recovery peptide research space. This article reviews the mechanistic and citation evidence behind BPC-157, TB-500, and... Read more...
BPC-157 & BPC 157: Muscle Protein Synthesis Research Data
Muscle Research Mechanism of Action Clinical Evidence Last Updated: May 2026 BPC-157 is a synthetic pentadecapeptide that has appeared in over 100 published research papers, with a significant portion of the preclinical literature examining its effects on tissue repair, angiogenesis, and muscle protein synthesis pathways. This article reviews what the published data actually shows about BPC 157 and its relationship to muscle protein synthesis in preclinical models — covering the proposed mechanisms, the specific rodent model findings, how BPC157 compares to structurally distinct peptides such as TB-500, and the published... Read more...
Where to Buy BPC Peptide: Research-Grade Supply UK
Research Supply UK Peptides BPC-157 Last Updated: May 2026 When researchers source BPC peptide for tissue and repair studies, the single biggest variable affecting the validity of their data is compound purity — and most of the market fails on this point before the experiment even begins. BPC-157 10mg is one of the most widely studied peptides in the current research literature, with a sequence of 15 amino acids and a published profile spanning tendon repair, gastrointestinal tissue, and neurological models. But the compound's research utility depends entirely on starting... Read more...
BPC vs TB500: Recovery Peptide Research Comparison
BPC vs TB500: Recovery Peptide Research Comparison | Pure Grade Labs Recovery Research Research Comparison Tissue Repair Last Updated: May 2026 BPC vs TB500: Recovery Peptide Research Comparison & Synergy BPC-157 and TB-500 are two of the most extensively studied tissue repair peptides in preclinical research, each operating through distinct molecular mechanisms — yet sharing overlapping applications in musculoskeletal, vascular, and inflammatory models. When researchers compare BPC-157 vs TB-500, they are evaluating two fundamentally different classes of compound. BPC-157 (also written as BPC157) is a synthetic pentadecapeptide derived from a... Read more...
IGF-1 LR3 Dosing & Safety for Research: Clinical Data
Growth Factor Research Safety Data Dosing Research Last Updated: May 2026 IGF-1 LR3 (Insulin-like Growth Factor-1 Long Arg3) is a synthetic, 83-amino acid analogue of endogenous IGF-1 engineered for extended circulating half-life and significantly reduced insulin-like growth factor binding protein (IGFBP) affinity — properties that have made it the subject of considerable published research into GH-axis biology, tissue anabolism, and metabolic signalling. Native IGF-1 is cleared from circulation in roughly 12–15 minutes; IGF-1 LR3, through a structural substitution of glutamate for arginine at position 3 and the addition of a... Read more...
Growth Stack: GHRP-2 + Ipamorelin + IGF-1 Research Guide
GH Research Research Combinations Mechanism of Action Last Updated: May 2026 The GHRP-2 + Ipamorelin + IGF-1 LR3 research combination targets the GH/IGF-1 axis at three sequential levels: GHS-R1a receptor activation to drive GH pulsatility (GHRP-2 and Ipamorelin), and direct IGF-1 receptor agonism at the tissue level (IGF-1 LR3) — bypassing the pituitary-hepatic GH-to-IGF-1 conversion step entirely and providing a direct anabolic signal at target cells. The mechanistic rationale for studying these compounds together is that each addresses a different bottleneck in the GH axis: GHRP-2 maximises GH pulse magnitude,... Read more...
BPC-157 + TB-500 + MOD-GRF Research Guide
Tissue Research Recovery Research Research Combinations Last Updated: May 2026 The BPC-157 + TB-500 + MOD-GRF research combination represents a three-tier approach to tissue repair that operates simultaneously at the local cellular level (BPC-157: FAK/paxillin, VEGFR2), the systemic inflammatory and progenitor level (TB-500: AKT/ILK, TNF-α suppression, VEGF), and the anabolic hormone axis (CJC-1295+DAC: GHRH receptor agonism, GH pulsatility, sustained IGF-1 elevation). Each compound addresses a distinct dimension of the tissue repair process — none of their primary mechanisms overlap, which is the defining feature that makes this research combination coherent... Read more...
MOD-GRF Dosing: Complete Research Guide | Pure Grade Labs
MOD-GRF Research GHRH Analogs Clinical Evidence Last Updated: May 2026 MOD-GRF 1-29 (Modified GRF 1-29, also called CJC-1295 without DAC) is a stabilised 29-amino acid analog of growth hormone-releasing hormone (GHRH) with a half-life of approximately 30 minutes — compared to the native GHRH half-life of just 2–4 minutes and the long-acting CJC-1295+DAC half-life of approximately 19 days. Understanding the dosing parameters tested in published research, the pharmacokinetic basis for these parameters, and how MOD-GRF 1-29 compares to its longer-acting counterpart is essential for researchers designing GH axis studies or... Read more...
Ipamorelin vs GHRP-2: Side Effects & Research
Comparison Study GH Research Mechanism of Action Last Updated: May 2026 Ipamorelin and GHRP-2 are both growth hormone secretagogues (GHS) that stimulate GH release via the ghrelin receptor (GHS-R1a) — but their selectivity profiles, off-target activity, and side effect characteristics differ significantly in published research, making the choice between them a meaningful research design decision rather than a matter of preference. Ipamorelin, described in its original 1998 European Journal of Endocrinology publication as "the first selective growth hormone secretagogue," stimulates a clean GH pulse with minimal cortisol, prolactin, or ACTH... Read more...
Peptides for Fat Loss: GLP-1 Research Overview
GLP-1 Research Metabolic Research Clinical Evidence Last Updated: May 2026 ⚠ Regulatory Notice: GLP-1 receptor agonists including semaglutide, tirzepatide, and retatrutide are prescription-only medications in many jurisdictions, including the UK. These compounds are supplied by Pure Grade Labs as research chemicals only. For research purposes only. Not for human consumption. The most clinically studied peptides in body composition research are GLP-1 receptor agonists — synthetic analogs of the natural glucagon-like peptide-1 hormone that have demonstrated significant fat mass changes in large-scale Phase 3 trials: semaglutide at 14.9% average body weight... Read more...
TB-500 for Muscle Wasting: Research Evidence & Mechanisms
Tissue Research Clinical Evidence Mechanism of Action Last Updated: May 2026 TB-500 (Thymosin Beta-4) has emerged as one of the most mechanistically well-characterised peptides in muscle wasting research — studied across cardiac atrophy, skeletal muscle injury, and inflammatory cachexia models for its activity on the AKT/PI3K survival pathway, satellite cell recruitment, and VEGF-mediated angiogenesis. Unlike single-pathway compounds, TB-500 operates across structural repair, inflammatory suppression, and vascular support simultaneously — which is why researchers studying muscle atrophy have returned to it across more than 200 published studies over two decades. Muscle... Read more...
Peptide Stacking for Muscle Growth: Research Guide
Compound Guides Protocol Research GH Secretagogues Tissue Research Last Updated: May 2026 Peptide stacking for muscle growth is one of the most searched topics in the research chemical space — and also one of the most poorly understood, because the "stacking" framing obscures what the science is actually describing: mechanistically independent compound pairings that activate distinct biological pathways simultaneously. In the preclinical literature, these multi-compound research combinations are investigated not because two peptides are "better than one" in some vague sense, but because their receptor targets don't overlap — which... Read more...
BPC-157 Dosing for Research: Protocol Guide
BPC-157 Research Protocol Tissue Research Compound Guide Dosing Research Last Updated: May 2026 BPC-157 is a synthetic 15-amino acid peptide derived from a gastric cytoprotective protein, with one of the most extensive preclinical research records of any compound in the tissue-repair peptide literature — spanning more than 40 published animal studies produced primarily by the Zagreb group (Sikiric et al.) since 1994. What separates BPC-157 from most synthetic peptides in research is its documented oral bioactivity: unlike the majority of peptides that are degraded in the gastrointestinal tract, BPC-157 maintains... Read more...
Selank: Anxiolytic Peptide & Cognitive Research Overview
Compound Guide Cognitive Research Anxiolytic Research Last Updated: May 2026 Selank is a synthetic heptapeptide analogue of tuftsin — a naturally occurring immunomodulatory tetrapeptide — that has been studied extensively in preclinical research for its anxiolytic profile, GABAergic modulation, enkephalinase inhibition, and cognitive enhancement properties. Developed at Russia's Institute of Molecular Genetics, Selank 10mg carries the sequence Thr-Lys-Pro-Arg-Pro-Gly-Pro — the natural tuftsin tetrapeptide (Thr-Lys-Pro-Arg) extended by three amino acids to improve metabolic stability and CNS bioavailability. Research literature documents a compound that modulates anxiety-related behaviour in rodent models without the... Read more...
Semax: Neuropeptide for Cognitive Enhancement Research
        Compound Guide     Cognitive Research     Neuropeptide     Last Updated: May 2026           Semax is a synthetic heptapeptide analogue of ACTH(4-10) — sequence Met-Glu-His-Phe-Pro-Gly-Pro — developed at the Institute of Molecular Genetics in Russia during the 1980s and 1990s, and subsequently approved in Russia for neurological research applications including stroke intervention and cognitive deficit models. Unlike native ACTH fragments, Semax incorporates a C-terminal Pro-Gly-Pro extension that confers resistance to dipeptidyl peptidase IV (DPP-IV) enzymatic degradation, dramatically extending its biological... Read more...
Growth Hormone Peptides: GHRP-2 vs Ipamorelin Research Guide
        Compound Guide     Growth Hormone Research     Research Comparison     Last Updated: May 2026           GHRP-2 and Ipamorelin are both growth hormone secretagogues that stimulate GH release by activating the ghrelin receptor (GHS-R1a) — but they differ critically in receptor selectivity, co-stimulation of cortisol and prolactin, and their pharmacological specificity profiles. GHRP-2 is a first-generation synthetic hexapeptide with strong GH-releasing activity accompanied by dose-dependent stimulation of cortisol and prolactin. Ipamorelin is a third-generation pentapeptide engineered specifically to maximise GHS-R1a... Read more...
Peptides for Joint Recovery Research: BPC-157 vs TB-500
        Compound Guide     Joint Research     Research Comparison     Last Updated: May 2026           Joint and connective tissue research represents one of the most active areas of peptide preclinical investigation, and two compounds dominate the published evidence base: BPC-157 and TB-500. Both have been studied in a range of musculoskeletal injury models — tendon, ligament, cartilage, and bone — but they do so via distinct molecular pathways, with different published evidence profiles, different model systems, and different mechanistic implications... Read more...
Growth Hormone Peptides: GHRP-2 vs Ipamorelin Research Guide
Compound Guide Growth Hormone Research Research Comparison Last Updated: May 2026 GHRP-2 and Ipamorelin are both growth hormone secretagogues that stimulate GH release by activating the ghrelin receptor (GHS-R1a) — but they differ critically in receptor selectivity, co-stimulation of cortisol and prolactin, and their pharmacological specificity profiles. GHRP-2 is a first-generation synthetic hexapeptide with strong GH-releasing activity accompanied by dose-dependent stimulation of cortisol and prolactin. Ipamorelin is a third-generation pentapeptide engineered specifically to maximise GHS-R1a selectivity while minimising off-target pituitary hormone release — a selectivity profile that has made it... Read more...
GHRP-2 Research Protocol: Mechanism, Trial Parameters & GH Axis
Growth Hormone Research Research Protocol Compound Guide Last Updated: May 2026 GHRP-2 (Growth Hormone Releasing Peptide-2, also known as pralmorelin) is a synthetic hexapeptide that acts as a selective agonist at the growth hormone secretagogue receptor (GHS-R1a), stimulating pulsatile growth hormone release through a mechanism distinct from — and synergistic with — the endogenous GHRH pathway. First characterised by Cyril Bowers in the early 1980s as part of the original enkephalin-derived GH-releasing series, GHRP-2 has since accumulated one of the most robust preclinical and clinical evidence bases among synthetic GH... Read more...
Peptide Stacking for Muscle Research: BPC-157, TB-500, Ipamorelin & CJC-1295
Research Combination Muscle Research Compound Guide Last Updated: May 2026 Multi-peptide research combination protocols — sometimes called "peptide stacking" in the research community — are preclinical study designs that administer two or more mechanistically distinct peptides to investigate whether independent signalling pathways produce complementary or additive effects in a given tissue or biological model. In muscle and connective tissue research, these protocols have become increasingly common as the published evidence base for individual compounds has matured enough to motivate investigation of their interactions. This article covers the scientific rationale for... Read more...
Tirzepatide (Mounjaro) Research: Mechanism, Clinical Data & Trial Parameters
GLP-1 Research Metabolic Research Clinical Evidence Last Updated: May 2026 Tirzepatide — marketed as Mounjaro for type 2 diabetes and Zepbound for obesity — is a 39-amino acid synthetic peptide that acts as a dual agonist at both the GIP (glucose-dependent insulinotropic polypeptide) receptor and the GLP-1 (glucagon-like peptide-1) receptor, representing the first of a novel class of twincretin compounds in clinical research. Published across the SURPASS and SURMOUNT trial programmes involving over 12,000 participants, tirzepatide has generated one of the most extensively characterised metabolic efficacy profiles of any peptide... Read more...
IGF-1 LR3 Research: Mechanism, GH Axis, and Muscle Biology
IGF-1 Research GH Axis Anabolic Signalling Last Updated: May 2026 IGF-1 LR3 (Insulin-like Growth Factor-1 Long Arg3) is an 83-amino acid synthetic analogue of human IGF-1, engineered with two structural modifications — an N-terminal 13-amino acid extension and a glutamic acid to arginine substitution at position 3 — that reduce binding to IGF-1 binding proteins and extend plasma half-life from approximately 15 minutes (native IGF-1) to 20–30 hours. This pharmacokinetic modification makes IGF-1 LR3 the primary IGF-1 analogue used in published research investigating the downstream anabolic signalling of the GH/IGF-1... Read more...
GHRP-6 vs GHRP-2: Research Comparison, Mechanism & GH Pulse Data
Compound Comparison GH Research Research Protocol Last Updated: May 2026 GHRP-6 and GHRP-2 are both synthetic hexapeptide agonists at the growth hormone secretagogue receptor type 1a (GHS-R1a), but published comparative research consistently demonstrates that GHRP-2 produces substantially higher GH pulse amplitudes — 6–10× above baseline versus 2–5× for GHRP-6 at equivalent molar doses — while generating a cleaner hormonal profile with less pronounced appetite stimulation and lower cortisol co-elevation. The distinction matters for research design: if the endpoint is maximum GH pulse amplitude, GHRP-2 is the superior tool. If appetite... Read more...
BPC-157 + TB-500: The Wolverine Recovery Research Stack Explained
Recovery Research Compound Combination Tissue Repair Last Updated: May 2026 BPC-157 and TB-500 are the two most extensively published synthetic peptides in musculoskeletal and soft tissue injury research, and they work through completely different mechanisms — making their combination the most scientifically coherent dual-compound research protocol in the injury repair literature. BPC-157 drives localised angiogenesis and growth factor upregulation at the injury site; TB-500 promotes systemic actin polymerisation, cell migration, and anti-inflammatory signalling. Together, they address the two primary rate-limiting steps in tissue repair that either compound cannot target alone.... Read more...
BPC-157 + TB-500 for Injury Research
Research Combination Injury Research Compound Guide Last Updated: May 2026 The "Wolverine Protocol" is a research community term for the combined investigation of BPC-157 and TB-500 - two synthetic peptides that have generated the most substantial published preclinical evidence base in musculoskeletal and soft tissue injury research contexts. The name is colloquial and informal, originating from online research communities referencing the Marvel character's accelerated tissue recovery. As a scientific description it is imprecise; as a search term it has become the dominant entry point for researchers and biology-curious individuals looking... Read more...
HGH Frag 176-191: What Researchers Need to Know
Compound Guide Growth Hormone Research Fragment Peptides Last Updated: May 2026 Research Use Only HGH fragment 176-191 is supplied by Pure Grade Labs strictly as a research chemical for laboratory use only. Not for human consumption. No medical claims are made. This article is educational in nature and does not constitute medical advice. HGH fragment 176-191 — commonly referred to in research literature as HGH frag or AOD-9604 precursor — is a 16-amino acid synthetic peptide derived from the C-terminal region of the full 191-amino acid human growth hormone (hGH)... Read more...
Retatrutide (Reta): Triple Incretin Research Guide
Compound Guide GLP-1 Research Clinical Evidence Last Updated: May 2026 Regulatory Notice Retatrutide is a Prescription-Only Medicine in many jurisdictions and is currently in Phase III clinical trials. This compound is supplied by Pure Grade Labs strictly as a research chemical. For research purposes only. Not for human consumption. Retatrutide — colloquially known as Reta — is a once-weekly triple incretin receptor agonist developed by Eli Lilly that simultaneously activates GLP-1R, GIPR, and the glucagon receptor (GcgR), making it the first published compound to achieve pharmacological tri-agonism across all three... Read more...
CJC-1295 DAC: Complete Research Guide & Mechanism Overview
Compound Guide GH Research GHRH Research Last Updated: May 2026 CJC-1295 with DAC (also written CJC1295 DAC) is a synthetic analogue of growth hormone releasing hormone (GHRH) engineered to resist enzymatic degradation and bind serum albumin, extending its half-life from under 10 minutes to approximately 6-8 days in published human pharmacokinetic studies. The DAC (Drug Affinity Complex) technology - a maleimidopropionic acid linker enabling covalent albumin binding - represents the same half-life extension strategy used in semaglutide, applied here to the GHRH axis rather than the GLP-1 axis. The result... Read more...
Ipamorelin Research: GH Secretagogue Mechanism & Evidence
Compound Guide GH Research Mechanism of Action Last Updated: May 2026 Ipamorelin is a synthetic pentapeptide growth hormone secretagogue that selectively activates the ghrelin receptor (GHSR-1a) to stimulate pulsatile growth hormone release — distinguished in published literature from earlier GHRPs by its high receptor selectivity and minimal effect on cortisol, prolactin, and ACTH at research doses. First characterised by Raun K et al. in 1998, ipamorelin's selectivity profile has made it one of the most studied GH secretagogues for research contexts where isolating GH pathway effects without concurrent stress hormone... Read more...
TB-500 vs BPC-157: Mechanism & Research Comparison
Comparison Study Clinical Evidence Tissue Research Last Updated: May 2026 TB-500 (also written TB500) and BPC-157 (also written BPC157) are the two most extensively studied synthetic peptides in musculoskeletal and connective tissue research — but they work through entirely different mechanisms, have different molecular origins, and are most accurately understood as complementary research tools rather than interchangeable compounds. Understanding the distinction matters for research design: choosing between them depends on which biological pathway you are investigating, not simply which tissue type you are studying. This article compares TB-500 and BPC-157... Read more...
Semaglutide (Ozempic) Research: GLP-1 Receptor Mechanism Explained
Compound Guide Clinical Evidence GLP-1 Research Last Updated: May 2026 Regulatory Notice Semaglutide is a prescription-only medication in many jurisdictions, including the UK. This compound is supplied by Pure Grade Labs strictly as a research chemical. For research purposes only. Not for human consumption. Semaglutide — the active molecule in Ozempic, Wegovy, and Rybelsus — is a GLP-1 receptor agonist that became one of the most clinically studied compounds of the past decade, generating data across more than 10 major randomised controlled trials involving tens of thousands of participants. The... Read more...
BPC-157 Mechanism & Research: 30 Years of Preclinical Evidence
Compound Guide Clinical Evidence Mechanism of Action Last Updated: May 2026 BPC-157 (Body Protection Compound-157) is a 15-amino acid synthetic pentadecapeptide derived from a protective sequence found in human gastric juice, with over 30 years of published preclinical research across musculoskeletal, gastrointestinal, and neurological models. First characterised by Professor Predrag Sikiric and his team at the University of Zagreb in the early 1990s, BPC-157 has accumulated one of the largest preclinical evidence bases of any synthetic peptide — with more than 100 peer-reviewed publications examining its molecular mechanisms across multiple... Read more...
Wolverine Protocol: BPC-157 and TB-500 Stack - What the Research Shows
Research Peptide Mechanisms Tissue Repair Last Updated: May 2026 The combination of BPC-157 and TB-500 has generated significant research interest in the context of tissue repair mechanisms. These two peptides have accumulated extensive preclinical research compared to most stacked pairs in laboratory contexts. This article covers what published data demonstrates—the mechanistic rationale, the research studies, and why scientists consider these two compounds complementary rather than redundant in their biological pathways. Research-Grade BPC-157 and TB-500 Pure Grade Labs supplies verified purity peptides for research purposes. Every batch is third-party tested with... Read more...
AOD-9604 Research Guide — HGH Fragment for Metabolic Studies
AOD-9604 HGH Fragment Fat Metabolism Last Updated: May 2026 AOD-9604 (CAS: 221231-10-3) is a synthetic 16-amino acid peptide fragment of human growth hormone, engineered to isolate fat-metabolising properties without activating the growth hormone receptor or raising IGF-1 levels. Preclinical research showed significant lipolytic effects in animal models. Six human clinical trials enrolled over 900 participants and confirmed the safety profile. AOD-9604 is closely related to HGH Fragment 176-191, though they differ chemically in important ways. Key Takeaways CAS number: 221231-10-3. Molecular weight: ~1,817 Da. 16 amino acids (Tyr-hGH 177-191). Source:... Read more...
UK Peptide Research: A Beginner's Complete Guide
Research Education Peptide Basics UK Compliance Last Updated: April 2026 Research peptides are short chains of amino acids used in laboratory and scientific research to study biological processes including tissue repair, hormone signalling, fat metabolism, and neuroprotection. In the UK, they are legal to purchase for research purposes, are not classified as controlled substances under the Misuse of Drugs Act 1971, and are available from specialist suppliers with third-party purity verification. This guide covers everything from the biology up: what peptides are, how different categories work, what a Certificate of... Read more...